Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection

Current Drug Discovery Technologies

Volumn 7, Issue 2, 2010, Pages 86-94

  Hong Geller, Elizabeth ^a   Micheva Viteva, Sofiya N ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Bacterial infection; Genomic screen; Host immune response; RNA interference; Target identification; Viral infection

Indexed keywords

BACTERIAL INFECTION; GENE FUNCTION; GENETIC ASSOCIATION; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VIRUS INFECTION;

EID: 78649561297     PISSN: 15701638     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016310793180657     Document Type: Review

References (55)

1. Cornelis GR. The type III secretion injectisome. Nat Rev Microbiol 2006; 4: 811-25.
2. An P, Winkler CA. Host genes associated with HIV/AIDS: advances in gene discovery. Trends Genet 2010; 26: 119-31.
3. Nagata K, Kawaguchi A, Naito T. Host factors for replication and transcription of the influenza virus genome. Rev Med Virol 2008; 18: 247-60.
4. Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: doublestranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000; 101: 25-33.
5. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNAdirected nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000; 404: 293-6.
6. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-11. (Pubitemid 28099681)
7. Clemens JC, Worby CA, Simonson-Leff N, et al. Use of doublestranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc Natl Acad Sci USA 2000; 97: 6499-503.
8. Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999; 286: 950-2.
9. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-8.
10. Kittler R, Surendranath V, Heninger AK, et al. Genome-wide resources of endoribonuclease-prepared short interfering RNAs for specific loss-of-function studies. Nat Methods 2007; 4: 337-44.
11. Prudencio M, Lehmann M. Illuminating the host - How RNAi screens shed light on host-pathogen interactions. Biotech J 2009; 4: 826-37.
12. Mylonakis E, Aballay A. Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infect Immun 2005; 73: 3833-41.
13. O'Callaghan D, Vergunst A. Non-mammalian animal models to study infectious disease: worms or fly fishing? Curr Opin Microbiol 2010; 13: 79-85.
14. Kuijl C, Savage ND, Marsman M, et al. Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 2007; 450: 725-30.
15. Forsberg M, Blomgran R, Lerm M, et al. Differential effects of invasion by and phagocytosis of Salmonella typhimurium on apoptosis in human macrophages: potential role of Rho-GTPases and Akt. J Leukoc Biol 2003; 74: 620-9.
16. Johannes L, Romer W. Shiga toxins-from cell biology to biomedical applications. Nat Rev Microbiol 2010; 8: 105-16.
17. Saenz J, Li J, Haslam D. The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response. Cell Microbiol 2010; 12(4): 516-29.
18. Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasitol 2006; 100: 415-31.
19. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010; 22: 28-33.
20. Tsao TC, Hong J, Huang C, Yang P, Liao SK, Chang KS. Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis. Tuber Lung Dis 1999; 79: 279-85.
21. Mishra B, Moura-Alves P, Sonawane A, Hacohen N, Griffiths G, Moita L, Anes E. Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 2010; 12(8): 1046-63.
22. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388: 621-5.
23. Cho J, Kim Y, Morrison S. Inhibitors of MyD88-dependent proinflammatory cytokine production identified utilizing a novel RNA interference screening approach. PLoS One 2009; 4: e7029.
24. Pizarro-Cerda J, Cossart P. Listeria monocytogenes membrane trafficking and lifestyle: the exception or the rule? Annu Rev Cell Dev Biol 2009; 25: 649-70.
25. Cheng L, Viala J, Stuurman N, Wiedemann U, Vale R, Portnoy D. Use of RNA interference in Drosophila S2 cells to identify host pathways controlling compartmentalizaton of an intracellular pathogen. Proc Natl Acad Sci 2005; 102: 13646-51.
26. Burrack L, Harper J, Higgins D. Perturbation of vacuolar maturation promotes listerollysin O-independent vacuolar escape during Listeria monocytogenes infection of human cells. Cell Microbiol 2009; 11: 1382-98.
27. Mota L, Ramsden A, Liu M, Castle J, Holden D. SCAMP3 is a component of the Salmonella-induced tubular network and reveals an interaction between bacterial effectors and post-Golgi trafficking. Cell Microbiol 2009; 11: 1236-53.
28. Galan JE, Zhou D. Striking a balance: modulation of the actin cytoskeleton by Salmonella. Proc Natl Acad Sci USA 2000; 97: 8754-61.
29. Ramsden AE, Holden DW, Mota LJ. Membrane dynamics and spatial distribution of Salmonella-containing vacuoles. Trends Microbiol 2007; 15: 516-24.
30. Ramsden AE, Mota LJ, Munter S, Shorte SL, Holden DW. The SPI-2 type III secretion system restricts motility of Salmonellacontaining vacuoles. Cell Microbiol 2007; 9: 2517-29.
31. Brass AL, Dykxhoorn DM, Benita Y, et al. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008; 319: 921-6.
32. Konig R, Zhou Y, Elleder D, et al. Global analysis of hostpathogen interactions that regulate early-stage HIV-1 replication. Cell 2008; 135: 49-60.
33. Zhou H, Xu M, Huang Q, et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008; 4: 495-504.
34. Yeung ML, Houzet L, Yedavalli VS, Jeang KT. A genome-wide short hairpin RNA screening of Jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem 2009; 284: 19463-73.
35. Li Q, Brass AL, Ng A, et al. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci USA 2009; 106: 16410-5.
36. Tai AW, Benita Y, Peng LF, et al. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 2009; 5: 298-307.
37. Supekova L, Supek F, Lee J, et al. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J Biol Chem 2008; 283: 29-36.
38. Ng TI, Mo H, Pilot-Matias T, et al. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology 2007; 45: 1413-21.
39. Randall G, Panis M, Cooper JD, et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA 2007; 104: 12884-9.
40. Rothwell C, Lebreton A, Young Ng C, et al. Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 2009; 389: 8-19.
41. Ang F, Wong AP, Ng MM, Chu JJ. Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus. Virol J 2010; 7: 24.
42. Krishnan MN, Ng A, Sukumaran B, et al. RNA interference screen for human genes associated with West Nile virus infection. Nature 2008; 455: 242-5.
43. Karlas A, Machuy N, Shin Y, et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010; 463: 818-22.
44. Konig R, Stertz S, Zhou Y, et al. Human host factors required for influenza virus replication. Nature 2010; 463: 813-7.
45. Prudencio M, Lehmann MJ. Illuminating the host - how RNAi screens shed light on host-pathogen interactions. Biotechnol J 2009; 4: 826-37.
46. Bushman FD, Malani N, Fernandes J, et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS Pathog 2009; 5: e1000437.
47. Berger KL, Cooper JD, Heaton NS, et al. Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication. Proc Natl Acad Sci USA 2009; 106: 7577-82.
48. Hao L, Sakurai A, Watanabe T, et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008; 454: 890-3.
49. Guinea R, Carrasco L. Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol 1995; 69: 2306-12.
50. Perez L, Carrasco L. Involvement of the vacuolar H(+)-ATPase in animal virus entry. J Gen Virol 1994; 75 ( Pt 10): 2595-606.
51. Elton D, Simpson-Holley M, Archer K, et al. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J Virol 2001; 75: 408-19.
52. Satterly N, Tsai PL, van Deursen J, et al. Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci USA 2007; 104: 1853-8.
53. Birmingham A, Selfors LM, Forster T, et al. Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods 2009; 6: 569-75.
54. Svoboda P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 2007; 9: 248-57.
55. Alvarez R, Elbashir S, Borland T, et al. RNA interferencemediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrob Agents Chemother 2009; 53: 3952-62.